Bio View (Israel) Top Management

BIOV Stock  ILS 26.20  0.90  3.56%   
Bio View employs about 35 people. The company is managed by 6 executives with a total tenure of roughly 56 years, averaging almost 9.0 years of service per executive, having 5.83 employees per reported executive. Analysis of Bio View's management performance can provide insight into the company performance.
Alan Schwebel  CEO
CEO and Pres
David Kutas  CEO
CEO of BioView Inc - USA and President of BioView Inc - USA
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio View. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Bio View Management Team Effectiveness

Bio View's management efficiency ratios could be used to measure how well Bio View manages its routine affairs as well as how well it operates its assets and liabilities.

Bio View Workforce Comparison

Bio View is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 10,935. Bio View adds roughly 35.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02.

Bio View Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Bio View Price Series Summation is a cross summation of Bio View price series and its benchmark/peer.

Bio View Notable Stakeholders

A Bio View stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bio View often face trade-offs trying to please all of them. Bio View's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bio View's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Alan SchwebelCEO and PresProfile
David KutasCEO of BioView Inc - USA and President of BioView Inc - USAProfile
Elad KfirVice President of MarketingProfile
Inbal HillelVice President - OperationsProfile
Yulia CPAChief OfficerProfile
Yuval MScEx VPProfile

About Bio View Management Performance

The success or failure of an entity such as Bio View often depends on how effective the management is. Bio View management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.
Please note, the presentation of Bio View's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio View's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bio View's management manipulating its earnings.

Bio View Workforce Analysis

Traditionally, organizations such as Bio View use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bio View within its industry.

Bio View Manpower Efficiency

Return on Bio View Manpower

Revenue Per Employee871.8K
Revenue Per Executive5.1M
Net Income Per Employee62.4K
Net Income Per Executive364K
Working Capital Per Employee514.3K
Working Capital Per Executive3M

Complementary Tools for Bio Stock analysis

When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets